HALEOS LABS Financial Statement Analysis
|
||
|
The Revenues of HALEOS LABS have increased by 12.67% YoY .
The Earnings Per Share (EPS) of HALEOS LABS has increased by 121.11 % YoY. |
||
HALEOS LABS Last 5 Annual Financial Results
[BOM: 540679|NSE : HALEOSLABS]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹345 Cr | ₹306 Cr | ₹316 Cr | ₹350 Cr | ₹266 Cr |
| Expenses | ₹300 Cr | ₹275 Cr | ₹287 Cr | ₹316 Cr | ₹235 Cr |
| Operating Profit (Excl OI) | ₹45 Cr | ₹31 Cr | ₹29 Cr | ₹35 Cr | ₹30 Cr |
| Other Income | ₹4.86 Cr | ₹3.83 Cr | ₹3.07 Cr | ₹1.74 Cr | ₹1.78 Cr |
| Interest | ₹8.77 Cr | ₹10 Cr | ₹6.87 Cr | ₹6.23 Cr | ₹4.60 Cr |
| Depreciation | ₹15 Cr | ₹15 Cr | ₹11 Cr | ₹10 Cr | ₹7.86 Cr |
| Profit Before Tax | ₹26 Cr | ₹9.85 Cr | ₹17 Cr | ₹33 Cr | ₹20 Cr |
| Profit After Tax | ₹19 Cr | ₹6.33 Cr | ₹11 Cr | ₹25 Cr | ₹14 Cr |
| Consolidated Net Profit | ₹20 Cr | ₹9.09 Cr | ₹11 Cr | ₹25 Cr | ₹14 Cr |
| Earnings Per Share (Rs) | ₹66.51 | ₹30.08 | ₹37.91 | ₹83.76 | ₹44.84 |
| PAT Margin (%) | 4.85 | 1.87 | 3.18 | 6.51 | 4.59 |
| ROE(%) | 10.03 | 3.66 | 7.09 | 17.98 | 11.07 |
| ROCE(%) | 12.60 | 7.42 | 9.44 | 18.42 | 12.96 |
| Total Debt/Equity(x) | 0.43 | 0.55 | 0.59 | 0.51 | 0.50 |
Key Financials |
||
| Market Cap | : | ₹ 499.0 Cr |
| Revenue (TTM) | : | ₹ 333.8 Cr |
| Net Profit(TTM) | : | ₹ 17.8 Cr |
| EPS (TTM) | : | ₹ 59.3 |
| P/E (TTM) | : | 28.0 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| HALEOS LABS | 22.3% | -1.6% | 29.8% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.7% | 6.4% | 12.1% |
| DIVIS LABORATORIES | 3% | 2.8% | 0.9% |
| TORRENT PHARMACEUTICALS | 2.3% | 9.1% | 44.6% |
| CIPLA | 0.3% | 6.1% | -3.7% |
| DR REDDYS LABORATORIES | -0.1% | 8.9% | 1.9% |
| MANKIND PHARMA | 1.8% | 6.7% | 8% |
| LUPIN | 2.9% | 9.5% | 24.5% |
| ZYDUS LIFESCIENCES | 1.7% | 6% | 12% |
HALEOS LABS Revenues
[BOM: 540679|NSE : HALEOSLABS]
| Y-o-Y | 12.67 % |
| 5 Yr CAGR | 6.74 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹345 Cr | 12.67 | |
| Mar2024 | ₹306 Cr | -3.04 | |
| Mar2023 | ₹316 Cr | -9.86 | |
| Mar2022 | ₹350 Cr | 31.81 | |
| Mar2021 | ₹266 Cr | - | |
HALEOS LABS Operating Profit
[BOM: 540679|NSE : HALEOSLABS]
| Y-o-Y | 44.45 % |
| 5 Yr CAGR | 10.50 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹45 Cr | 44.45 | |
| Mar2024 | ₹31 Cr | 8.31 | |
| Mar2023 | ₹29 Cr | -16.53 | |
| Mar2022 | ₹35 Cr | 14.17 | |
| Mar2021 | ₹30 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 28.24 % |
| 5 Yr CAGR | 3.52 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 13.08% | 28.24 | |
| Mar2024 | 10.2% | 11.72 | |
| Mar2023 | 9.13% | -7.40 | |
| Mar2022 | 9.86% | -13.43 | |
| Mar2021 | 11.39% | - | |
HALEOS LABS Profit After Tax
[BOM: 540679|NSE : HALEOSLABS]
| Y-o-Y | 121.15 % |
| 5 Yr CAGR | 10.36 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹20 Cr | 121.15 | |
| Mar2024 | ₹9.09 Cr | -20.68 | |
| Mar2023 | ₹11 Cr | -54.73 | |
| Mar2022 | ₹25 Cr | 86.78 | |
| Mar2021 | ₹14 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 159.36 % |
| 5 Yr CAGR | 1.39 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 4.85 % | 159.36 | |
| Mar2024 | 1.87 % | -41.19 | |
| Mar2023 | 3.18 % | -51.15 | |
| Mar2022 | 6.51 % | 41.83 | |
| Mar2021 | 4.59 % | - | |
HALEOS LABS Earnings Per Share (EPS)
[BOM: 540679|NSE : HALEOSLABS]
| Y-o-Y | 121.11 % |
| 5 Yr CAGR | 10.36 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹67 | 121.11 | |
| Mar2024 | ₹30 | -20.65 | |
| Mar2023 | ₹38 | -54.74 | |
| Mar2022 | ₹84 | 86.80 | |
| Mar2021 | ₹45 | - | |
HALEOS LABS Return on Capital Employed (ROCE)
[BOM: 540679|NSE : HALEOSLABS]
| Y-o-Y | 69.81 % |
| 5 Yr CAGR | -0.70 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 12.6% | 69.81 | |
| Mar2024 | 7.42% | -21.40 | |
| Mar2023 | 9.44% | -48.75 | |
| Mar2022 | 18.42% | 42.13 | |
| Mar2021 | 12.96% | - | |
HALEOS LABS Share Price vs Sensex
| Current Share Price | : | ₹1,663.3 |
| Current MarketCap | : | ₹ 499.0 Cr |
| Updated EOD on | : | Jul 03,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HALEOS LABS | 22.3% |
-1.6% |
29.8% |
| SENSEX | 0.9% |
4.2% |
-6% |
HALEOS LABS related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about HALEOS LABS Financials
How the annual revenues of HALEOS LABS have changed ?
The Revenues of HALEOS LABS have increased by 12.67% YoY .
How the Earnings per Share (EPS) of HALEOS LABS have changed?
The Earnings Per Share (EPS) of HALEOS LABS has increased by 121.11 % YoY .
Check out Intrinsic Value of Peers of HALEOS LABS
Compare Stock Analytics of Peers of HALEOS LABS
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
